ADVERTISEMENT

GSK Pharma Q2 Review - Operating Leverage Expands Margin: Centrum Broking

GSK Pharma Q2 Review - Operating Leverage Expands Margin: Centrum Broking

Inside GlaxoSmithKline Pharmaceuticals’ Albendazole facility in Nashik, India. (Photographer: Kuni Takahashi/Bloomberg)  
Inside GlaxoSmithKline Pharmaceuticals’ Albendazole facility in Nashik, India. (Photographer: Kuni Takahashi/Bloomberg)  
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More